📰 Cocoon Platform News
Cocoon Platform News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cocoon Platform. Real-time updates on events, politics, business and more.
December 15, 2021
Incorporation of Agilent’s analytical technologies into Lonza’s Cocoon® platform will improve quality and consistency, leading to increased access to personalized medicines, according to officials at both companies. Collaboration aims to develop and integrate current and new analytical technologies into patient-scale cell therapy manufacturing workflows with the Cocoon Platform. The companies also aim to define the ideal Critical Quality Attributes required for cell therapies.
December 2, 2021
/PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a biotech company pioneering next-generation cell therapies for hard-to-treat cancers, today announces...
December 2, 2021
- Leucid will work with Lonza on the Cocoon Platform for Leucid Bio's Phase I/II clinical studies with its lead candidate, LEU-011, for the treatment of platinum resistant ovarian cancer -
December 2, 2021
/PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a biotech company pioneering next-generation cell therapies for hard-to-treat cancers, today announces...